Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,523 | -42,538 | -26,060 | -11,726 | -35,220 |
| Depreciation Amortization | 266 | 241 | 146 | 72 | 285 |
| Accounts receivable | 326 | 326 | 65 | 326 | -326 |
| Accounts payable and accrued liabilities | -477 | -1,868 | -1,031 | -1,868 | 3,027 |
| Other Working Capital | 1,343 | 1,832 | 1,326 | -168 | 487 |
| Other Operating Activity | 5,146 | 5,316 | 3,523 | 2,660 | 840 |
| Operating Cash Flow | $-48,919 | $-36,691 | $-22,031 | $-10,704 | $-30,907 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -766 | -952 | -662 | N/A | -80 |
| Investing Cash Flow | $-766 | $-952 | $-662 | $0 | $-80 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,733 | 6,342 | 4,242 | 1,630 | 75,299 |
| Other Financing Activity | 16,844 | 16,920 | 0 | 0 | 0 |
| Financing Cash Flow | $23,577 | $23,262 | $4,242 | $1,630 | $75,299 |
| Beginning Cash Position | 46,951 | 46,951 | 46,951 | 46,951 | 2,639 |
| End Cash Position | 20,843 | 32,570 | 28,500 | 37,877 | 46,951 |
| Net Cash Flow | $-26,108 | $-14,381 | $-18,451 | $-9,074 | $44,312 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,919 | -36,691 | -22,031 | -10,704 | -30,907 |
| Capital Expenditure | -766 | -952 | -662 | N/A | -80 |
| Free Cash Flow | -49,685 | -37,643 | -22,693 | -10,704 | -30,987 |